IHS Chemical Week

Regions :: Western Europe :: Netherlands

Johnson & Johnson Buys 18% Stake in Crucell

7:12 AM MDT | September 30, 2009 | Deepti Ramesh

Biopharmaceutical company Crucell (Leiden, Netherlands) says that Johnson & Johnson (J&J), through its affiliate JHC Nederland, has purchased about 18% of Crucell’s outstanding ordinary shares for a total purchase price of €302 million ($441 million). Crucell and J&J have also entered into a strategic collaboration for the discovery, development and commercialization of monoclonal antibodies and vaccines for the treatment and prevention of influenza and other infectious and non-infectious diseases, Crucell says. The companies have agreed to...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa